Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012)

Tg Therapeutics' (TGTX) quarterly Preferred Shares came in at $1109.0 in Q1 2012, up 168.52% quarter-over-quarter from $413.0 in Q4 2011.

Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012) Analysis & Trends

Tg Therapeutics' Preferred Shares history runs 2 years deep, the most recent figure standing at $1109.0 for Q1 2012.

On a quarterly basis, Preferred Shares changed N/A year-over-year to $1109.0 in Q1 2012; TTM through Mar 2012 was $1109.0, a N/A change from a year earlier, with the FY2012 full-year figure at $1109.0, changed N/A from the prior year.
Preferred Shares climbed to $1109.0 in Q1 2012 per TGTX's latest filing, from $413.0 in the prior quarter.
Across five years, Preferred Shares topped out at $1109.0 in Q1 2012 and bottomed at $413.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Tg Therapeutics	8.88 Bn	8.80 Bn	171.41 Mn	-

Download Data

Date	Value
Mar 31, 2012	1,109.00
Dec 31, 2011	413.00